Zurcher Kantonalbank (Zurich Cantonalbank) Pliant Therapeutics, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 8,030 shares of PLRX stock, worth $24,090. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,030
Previous 8,030
-0.0%
Holding current value
$24,090
Previous $90,000
16.67%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PLRX
# of Institutions
175Shares Held
64.8MCall Options Held
228KPut Options Held
772K-
Deep Track Capital, LP Greenwich, CT5.97MShares$17.9 Million3.46% of portfolio
-
Black Rock Inc. New York, NY4.97MShares$14.9 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.63MShares$13.9 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.23MShares$9.69 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.2MShares$9.59 Million1.61% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $146M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...